[Other] Erratum: Efficacy and Safety of Camrelizumab Plus Apatinib in Patients With Refractory Chordoma: A Phase II Clinical Trial

eraswr Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-06 19:12
Reward10points

journalㄩJournal of Clinical Oncology

AuthorsㄩCheng Yang; Qi Jia; Chenglong Zhao; Xinghai Yang; Haifeng Wei; Tielong Liu; Jian Jiao; Zhipeng Wu; Jian Zhao; Wei Xu; Zhenhua Zhou; Wei Wan; Weiwei Zou; Zhi Zhu; Xiaomei Ma; Qi Chen; Wei Guo; Dongqing Zhu; Tao Tan; Yan Lou; Juelan Ye; Jingyu Xing; Hao Zhang; Zijie Yuan; Jianru Xiao

Published dateㄩ2026-7-1

DOIㄩ10.1200/jco-26-01304

PDF linkㄩhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO-26-01304

Article linkㄩhttps://doi.org/10.1200/jco-26-01304

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    0


Return to the list